Related Experiment Video
Updated: May 28, 2025

Multidimensional Coculture System to Model Lung Squamous Carcinoma Progression
Published on: March 17, 2020
Integrative Multi-omics Analysis and Mendelian Randomization Reveal Potential Therapeutic Targets and their
Youpeng Chen1, Enzhong Li2, Zhenglin Chang1
1State Key Laboratory of Respiratory Disease, Department of Clinical Laboratory, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Institute of Respiratory Health, Guangzhou Medical University, Guangzhou, 510140, China.
Background:
Lung Squamous Cell Carcinoma (LUSC), a major subtype of non-small cell lung cancer, presents significant treatment challenges due to limited targeted therapy options. This study aims to identify novel therapeutic targets to improve therapeutic strategies for LUSC.
Methods:
By employing bulk RNA sequencing, Weighted Gene Co-expression Network Analysis (WGCNA), survival analysis, and Mendelian Randomization (MR), we pinpointed genes with prognostic relevance to LUSC. These genes were further scrutinized for their therapeutic potential through LASSO regression, Protein-Protein Interaction (PPI) network analysis, and immune infiltration assessments. To delve into the roles and cell-specific expressions of these genes within the LUSC microenvironment, pathway enrichment analysis, single-cell RNA sequencing (scRNA-seq), and pseudotime analysis were conducted.
Results:
Our integrative approach identified 23 prognostically significant therapeutic targets, categorized into tier-one, tier-two, and tier-three genes based on their potential therapeutic relevance. Functional enrichment analyses highlighted the significant role of these genes in immune response regulation, particularly in T-cell receptor signaling and the complement system. scRNA-seq analysis revealed cell-type-specific expression patterns and pseudotime analysis provided insights into cellular heterogeneity and developmental trajectories in LUSC.
Conclusion:
In this study, we identified 3 tier-one genes (MCM6, C4B, CTC-463A16.1), 7 tier-two genes (C4A, HLA-DRB9, LIMS2, LINC00654, MYO7B, SIGLEC5, TIE1), and 13 tier-three genes (AC007743.1, AC147651.4, ALDH2, BTN3A2, BTNL9, CCR1, GIPC3, HLA-DQB1, ICAM5, LIMD1, PM20D1, RP11-302L19.3, RP11-768F21.1).
Insights
This study identifies 23 novel therapeutic targets for Lung Squamous Cell Carcinoma (LUSC) by analyzing gene expression and patient data. These findings offer new avenues for LUSC treatment strategies.
Area of Science:
- Oncology
- Genomics
- Immunology
Background:
- Lung Squamous Cell Carcinoma (LUSC) is a major non-small cell lung cancer subtype with limited targeted therapy options.
- Identifying novel therapeutic targets is crucial for improving LUSC treatment strategies.
Purpose of the Study:
- To identify and characterize novel prognostic and therapeutic targets for LUSC.
- To explore the functional roles and expression patterns of these targets within the LUSC tumor microenvironment.
Main Methods:
- Utilized bulk RNA sequencing, Weighted Gene Co-expression Network Analysis (WGCNA), survival analysis, and Mendelian Randomization (MR) to identify prognostic genes.
- Employed LASSO regression, Protein-Protein Interaction (PPI) network analysis, and immune infiltration assessments to evaluate therapeutic potential.
- Conducted pathway enrichment analysis, single-cell RNA sequencing (scRNA-seq), and pseudotime analysis to understand gene functions and cell-specific expression.
Main Results:
- Identified 23 prognostically significant therapeutic targets for LUSC, categorized into tier-one, tier-two, and tier-three genes.
- Functional enrichment revealed significant roles in immune response regulation, including T-cell receptor signaling and the complement system.
- scRNA-seq and pseudotime analyses elucidated cell-type-specific expression patterns and cellular heterogeneity within the LUSC microenvironment.
Conclusions:
- Successfully identified a set of 23 novel therapeutic targets for LUSC.
- Highlighted the importance of immune-related pathways and cell-specific gene expression in LUSC pathogenesis.
- These identified genes represent promising candidates for future therapeutic development in LUSC.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Abnormal Proliferation

